Clinical outcomes of interlocking main pancreatic duct-jejunal internal bridge drainage in middle pancreatectomy: A comparative study

Table 1 Demographics and patient characteristics of the study cohort

	IMPD-J bridge drainage (n = 23)	Duct-to-mucosa pancreaticojejunostomy (n = 30)	χ²/t/z	P value
Age, years, n (%)	57.0 (52.0, 64.0)	61.0 (51.0, 67.0)	0.944	0.345
Male, n (%)	12 (52.2)	15 (50.0)	0.025	0.875
Female, n (%)	11 (47.8)	15 (50.0)
BMI, kg/m2	23.2 (20.4, 24.6)	22.2 (19.6, 23.4)	-1.212	0.225
Smoking, n (%)	7 (30.4)	15 (50.0)	2.053	0.152
Alcohol consumption, n (%)	7 (30.4)	4 (13.3)	2.315	0.128
Hypertension, n (%)	5 (21.7)	8 (26.6)	0.171	0.679
Diabetes, n (%)	10 (43.5)	7 (23.3)	2.425	0.119
WBC, 109/L	5.3 (4.7, 5.8)	5.0 (4.9, 6.1)	0.117	0.907
Neutrophils, 109/L	2.8 (2.5, 3.1)	3.0 (2.6, 3.6)	0.808	0.419
Platelet, 109/L	224.7 ± 63.1	198.3 ± 55.3	1.619	0.112
Albumin, g/L	42.6 ± 3.9	41.9 ± 3.8	0.480	0.633
Prealbumin, mg/dL	20 ± 10	20 ± 10	0.03	0.977
Total bilirubin, μmol/L	11.4 (6.7, 15.9)	11.4 (10.1, 14.5)	0.188	0.851

IMPD-J: Interlocking main pancreatic duct-jejunal; BMI: Body mass index; WBC: White blood cells.